NCT04192968

Brief Summary

The objective of the study is to compare the responses recorded with automated cortical auditory evoked potentials, of children who had one or two cochlear implants for 3 years, and the results of the speech therapy assessment. 24 patients in the main ImplantHear3 study presented with disappointing language development or poor cortical responses. These patients will be followed up once a year, during a visit scheduled for the usual care, until 6 years post-implant, in order to make it possible to objectify the quality of the auditory rehabilitation received by the child.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

January 13, 2020

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2024

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

4.3 years

First QC Date

December 6, 2019

Last Update Submit

September 8, 2025

Conditions

Keywords

Cochlear implantationAutomated cortical auditory evoked potentialsSpeech-language therapyChildrenCortical auditory evoked potentialsElectrical potentials via the implant

Outcome Measures

Primary Outcomes (2)

  • Automated cortical auditory evoked potentials results

    Latency and amplitude of the waves P1, N1, P2, N2.

    Annual assessment performed during 3 years.

  • Speech therapy result

    Percentage of recognition Open Set Words : * cochlear implant 1, * cochlear implant 2, * 2 cochlear implants together, * cochlear implant and hearing aid together.

    Annual assessment performed during 3 years.

Secondary Outcomes (12)

  • Value of p (HearLab)

    Annual assessment performed during 3 years.

  • Latencies P1, N1, P2, N2 (HearLab)

    Annual assessment performed during 3 years.

  • Amplitudes P1, N1, P2, N2 (HearLab)

    Annual assessment performed during 3 years.

  • Setting parameters

    Annual assessment performed during 3 years.

  • Auditory rehabilitation

    Annual assessment performed during 3 years.

  • +7 more secondary outcomes

Study Arms (2)

Patients

Children implanted cochlear since 3 years in uni or bilateral and followed in the pediatric otolaryngology department of Necker-Enfants Malades Hospital.

Other: Cortical auditory evoked potentials

Patients with disappointing language development or poor cortical responses

Children having participated in the main ImplantHear3 study and who present with disappointing language development or poor cortical responses.

Other: Additional exams

Interventions

Recording of automated cortical auditory evoked potentials in response to a vocal stimulus.

Patients

* Cortical auditory evoked potentials Recording of automated cortical auditory evoked potentials in response to a vocal stimulus. * Recording of cortical auditory evoked potentials in response to a click * Realization of electrical potentials via the implant Followed up once a year during a visit scheduled for usual care, for 3 years, that to say up to 6 years post-implant.

Patients with disappointing language development or poor cortical responses

Eligibility Criteria

Age42 Months - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children implanted for 3 years, in unilateral or bilateral and followed in the pediatric otolaryngology department of the Necker-Enfants Malades Hospital in Paris.

You may qualify if:

  • Patient who has received one or two cochlear implants between August 1, 2016 and November 1, 2017 and after 3 years of follow-up for the first implant.
  • Non-opposition of the holders of the parental authority and the patient.

You may not qualify if:

  • Patients over 15 years of age at implantation.
  • Patient relocated between August 1, 2016 and November 1, 2017.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Necker-Enfants Malades

Paris, 75015, France

Location

MeSH Terms

Conditions

Communication Disorders

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Natalie Loundon, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
  • Isabelle Rouillon, MD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2019

First Posted

December 10, 2019

Study Start

January 13, 2020

Primary Completion

April 13, 2024

Study Completion

April 13, 2024

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations